| Tyzeka (telbivudine) / Novartis |
NCT00467545: An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B |
|
|
| Completed | 4 | 44 | RoW | telbivudine | Novartis Pharmaceuticals | Chronic Hepatitis B | 09/09 | 09/09 | | |
NCT00646503: Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B |
|
|
| Completed | 4 | 150 | RoW | Telbivudine, SEBIVO, TYZEKA | Novartis | Hepatitis B, Chronic | 09/09 | 09/09 | | |
NCT00606099: Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B |
|
|
| Withdrawn | 4 | 0 | US | telbivudine, adefovir dipivoxil | Novartis | Chronic Hepatitis B | 11/09 | | | |
| Completed | 4 | 2200 | RoW | Telbivudine | Novartis Pharmaceuticals | Chronic Hepatitis B | 09/10 | 09/10 | | |
NCT00409019: Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy |
|
|
| Withdrawn | 4 | 0 | US | Telbivudine, Adefovir, Tenofovir | Novartis Pharmaceuticals | Chronic Hepatitis B | 03/11 | | | |
NCT00862706: Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks |
|
|
| Withdrawn | 4 | 0 | US | Telbivudine/LDT600A | Novartis Pharmaceuticals | Compensated Chronic Hepatitis B | 04/11 | 04/11 | | |
NCT00537537: To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB) |
|
|
| Completed | 4 | 100 | RoW | Telbivudine | Novartis Pharmaceuticals | Hepatitis B, Chronic | 06/11 | | | |
NCT00651209 / 2007-004845-14: A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB) |
|
|
| Completed | 4 | 105 | Europe, RoW | Tenofovir, Sebivo, Tyzeka, Viread | Novartis Pharmaceuticals | Hepatitis B, Chronic | 12/11 | | | |
NCT00962533: EFFicacy Optimization Research of Telbivudine Therapy |
|
|
| Completed | 4 | 606 | RoW | telbivudine, Sebivo® | Nanfang Hospital of Southern Medical University, Major Science and Technology Special Project of China Eleventh Five-year, Novartis | Hepatitis B, Chronic | 04/12 | 08/12 | | |
